-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_disposition-comments.pdf
April 25, 2013 - This issue is also
relevant to the decision analysis and model discussed on page
117 (see additional … Not discussed in report. … Amgen has already updated
the labeling for ESAs to account for studies assessed by AHRQ as discussed … Amgen also suggests that
the authors include an acknowledgement that the evidence base discussed in … The issue of radiotherapy trials has been
discussed.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-update_disposition-comments.pdf
August 16, 2016 - This concept has been discussed
in summaries and the Discussion. … We discussed this but have elaborated
more fully in the limitations. … Future subanalyses
are also now discussed.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medication-adherence-interventions_disposition-comments.pdf
September 11, 2012 - must
be acknowledged, and the limitations this imposed on the applicability of
the review must be discussed … Already discussed in the first paragraph under
methodological limitations
Peer Reviewer #9 Discussion … We have discussed this issue under
methodological limitations. … summarized some cross-cutting themes in
the future research section
Richard Chapell Discussion As discussed … above under "Methods," the literature on adherence is
considerably larger than the literature discussed
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/public-reporting-quality-improvement_disposition-comments.pdf
July 26, 2012 - This issue was
discussed in the Discussion/ Limitation section. … This is now stated in the introduction and also
discussed as a limitation. … This is discussed
in the limitations of this review. … Confounding and the difficulty in
studying/isolating the impact of public reporting
are discussed in … ACS would argue that
both of these important findings should be discussed in the AHRQ the
report.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-prognostic_methods.pdf
July 01, 2012 - evidence for prognostic tests are similar to those used in the review of a
diagnostic test and are discussed … Systematic
reviews of predictive test/treatment interactions are not specifically discussed in this … proof-of-concept
questions, all studies that included the test variable should be sought out, reviewed, and
discussed … Several issues discussed herein will need to be addressed when
planning and conducting a review.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-treatment-adherence_disposition-comments.pdf
December 20, 2012 - In particular, a number of
existing studies have discussed in
detail the methods for collecting
adherence … One suggestion
would be to reframe the outcomes discussed in the results
through the KQ for each level … We discussed the limited application of
current findings to patients receiving
protease inhibitors … We also discussed how the
increased pill burden may affect
adherence in the future research
section … excellent
overview of the level of evidence for each key question by
group -applicability is clearly discussed
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ems-911-workforce-mental-health-disposition-comments.pdf
February 28, 2025 - Comments on the Introduction section of the draft
report:
Employee assistance programs don't seem to be discussed
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pneumonia-antibiotic-treatment_disposition-comments.pdf
November 24, 2014 - – discussing the increasing incidence of
multi drug resistant Gram-negative organisms (partially
discussed … included in the background section of the report
where optimal dosing based on PK/PD principles is discussed … study, discussion about the major findings were
nicely stated and obvious limitations were adequately
discussed … During the early stages of the systematic review phase, the key
questions were discussed with our Technical … The lack of
studies linking PK/PD to clinical (patient-centered) outcomes in
this setting has been discussed
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout-diagnosis-disposition-160727.pdf
February 24, 2016 - We modified our conclusion about
US, and discussed possible reasons for the
wide variation in sensitivity … outcome measures
are appropriate, although the gold standard
itself has it own many limitations as
discussed … It is now discussed in the
Discussion section (Findings in Relation to What
is Already Known). … both parts of the question
should be addressed here and these two very
separate issues should be discussed … We substantially expanded the Research Gaps
section and discussed the issues related to
misdiagnosis
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/preterm-birth-terbutaline-pump_disposition-comments.pdf
September 01, 2011 - 6 Methods The potential for bias against publication of negative studies should
be considered and discussed … Results The likelihood of double-counting, while a possibility, is almost
impossible as the studies discussed … the low strength of evidence and
then again discussing the limitations/quality of
included studies discussed
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_disposition-comments.pdf
April 01, 2012 - While many of
these factors are discussed in the companion review on screening
for glaucoma, not all … These results are indeed discussed along with the key
point that the assessment of QOL was done after … Concentration of mitomycin is
not discussed in the report.(Lee SJ, Paranhos A, Shields MB. … Other similar procedures are not discussed, including
Trabectome and endocyclophotocoagulation, which … Public
comment/
AAO-AGS
Results Key Question3b
Aqueous humor shunts are not discussed at all in
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-surgery-preparation_disposition-comments.pdf
April 30, 2014 - We have
discussed designs that can be used to evaluate
the effect of oral antibiotics in combination … The issue of VTE was discussed (in varying levels
of details) in each of the TEP teleconferences we … We have provided the requested information in
the Results section and have discussed its
implications … We have discussed the implications of
inconsistent reporting the Final Report. … TEP #7
Conclusion The limitations are also properly discussed. Thank you.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-269-respectful-maternity-care-disposition-comments.pdf
January 02, 2024 - ES
Abstract
Suggest incorporating into the Conclusions paragraph of the ABSTRACT considerations
discussed … As discussed in
section 3.3.1, The
revised Childbirth
experience
questionnaire (CEQ-
2) also demonstrates … Suggest incorporating into the Conclusions paragraph of the ABSTRACT considerations
discussed later
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-dispositIon-comments-2022.pdf
January 01, 2022 - common in research involving mental
health conditions and behavioral interventions but aren’t
usually discussed … at length by review authors and I
appreciated the transparency and detail with which the
authors discussed … PICOTS table, I am unclear when it says “Any overall
PTSD outcome,”- what about the other outcomes discussed
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/dementia-nursing-home-characteristics_disposition-comments.pdf
October 23, 2012 - TEP Reviewer
#1
Executive
Summary
ES-14, line 10: Can applicability be better discussed? … This consideration was discussed with our
Technical Expert Panel, as well. … Peer Reviewer
#1
Discussion There are findings, and they are discussed very nicely. … We discussed blinding and sample size as research
challenges to point out that to determine the effectiveness … The authors and TEP undoubtedly discussed such a
logic train in detail.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/suicidal-thoughts-youth-disposition-comments.pdf
April 10, 2025 - At minimum,
this needs to be discussed in the paper. … Many health systems and
national medical organizations recommend using a
variety of the studies discussed … appreciate however
pointing out this study,
and we have added it to
the discussion section
and discussed
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendicitis_disposition-comments.pdf
December 14, 2015 - We have discussed these potential sources of bias
extensively in the Results and Discussion sections … We have discussed these potential sources of bias
extensively in the Results and Discussion sections … We have discussed these potential sources of bias
extensively in the Results and Discussion sections … We have discussed our meta-regression results more
extensively. … This
is the key idea behind repeat testing with deferred
treatment, an issue that is now discussed
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_clinician.pdf
November 01, 2016 - Points to be discussed with
patients and their caregivers include:
��That some types of behavioral programs
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cerebral-palsy-feeding_disposition-comments.pdf
March 20, 2013 - Peer reviewer
#4
Discussion/conclusion Some research gaps are discussed and the need for good
RCT … conclusion The ethical implications of conducting comparative studies
of surgical interventions is discussed … yes
Limitation adequately discussed? yes Omission of
literature?
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-252-infantile-epilepsies-executive-summary.pdf
October 01, 2022 - We discussed all
included studies narratively, and we rated the strength of evidence (SOE) using EPC